Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study
Charité - Universitätsmedizin Berlin · Cornell University · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
538
total citations
- FWCI
- 20.41
- Percentile
- 100%
- References
- 37
Citations per year
Authors
15Topics & keywords
Topics
Keywords
- Medicine
- Taxane
- Trastuzumab
- Trastuzumab emtansine
- Clinical endpoint
- Internal medicine
- Regimen
- Tolerability
No related works found for this paper.